PRL and Alzheimer disease: Evidence has suggested that the somatostatin expression is downregulated in early aging brains in snoring samples, leading to a progressive decrease in PRL and neprilysin activity and resulting in amyloid b (Ab) peptide accumulation in AD patients (Cao et al., 2021).